# US 2016/0256084 A1 · Device and mechanism for facilitating non-invasive, non-piercing monitoring of blood glucose > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2016/0256084 A1 - Document ID: US20160256084A1 - Status: Published application - Kind: A1 - Application number: 14/424,931 - Filed: 2014-06-10 - Published: 2016-09-08 - Earliest claimed: 2014-02-28 - Assignees: Tech4Life Enterprises Canada Inc. - Applicants: Tech4Life Enterprises Canada, Inc. - Inventors: SHARIQ RAMZAN ALI KHOJA; MUHAMMAD ABDUL MUQEET; SYEDA SUHA TIRMIZI; HAFIZ IMTIAZ AHMED; SAAD ABDULLAH - Web page: https://patentgrep.com/patent/US20160256084A1 ## CPC - A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement} - A61B 5/1172: using fingerprinting - A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes} - A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters - A61B 5/6826: {Finger} - A61B 5/6838: {Clamps or clips} - A61B 5/7225: {Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation (input circuits for detecting, measuring, or recording bioelectric or biomagnetic signals A61B5/30; specific diagnostic methods using bioelectric or biomagnetic signals A61B5/316)} - A61B 5/7278: {Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals} - A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)} - A61B 5/1495: Calibrating or testing of in-vivo probes - A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor} - A61B 2560/0223: of calibration, e.g. protocols for calibrating sensors - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) ## Abstract A mechanism is described for facilitating non-invasive and non-skin piercing monitoring of blood glucose according to one embodiment. A method of embodiments, as described herein, includes receiving a body part including a finger, where the body part in the placement area causes interruptions in the running of a light. The method may further include detecting initial readings corresponding to the interruptions, the initial readings including signals, where a signal is generated each time the light is interrupted while passing through the body part, calculating absolute values based on the initial readings, and computing a final glucose reading based on the absolute values. ## Claims ### Claim 1 An apparatus comprising: a placement area to receive a body part including a finger, wherein the body part in the placement area causes interruptions in the running of a light; observation/reading logic to detect initial readings corresponding to the interruptions, the initial readings including signals, wherein a signal is generated each time the light is interrupted while passing through the body part; absolute value computation module of calibration logic to calculate absolute values based on the initial readings; and predictive analysis logic to compute a final glucose reading based on the absolute values. ### Claim 2 (depends on 1) The apparatus of claim 1, further comprising a light source to emit the light within the apparatus, wherein the light is received at a light sensor and runs in beams including an emitting beam and a receiving beam, wherein the final glucose reading is computed without having to pierce or pinch the body part. ### Claim 3 (depends on 1) The apparatus of claim 1, further comprising sampling device and presentation logic to prepare the final glucose reading for presentation at a display screen, wherein the display screen to display the glucose reading. ### Claim 4 (depends on 1) The apparatus of claim 1, further comprising detection (interruption) logic to detect the interruptions causing the signals, wherein the signals include analog signals. ### Claim 5 (depends on 4) The apparatus of claim 4, further comprising signal conversion logic to convert the analog signals into digital signals, wherein the absolute values are computed based on the initial readings including the digital signals. ### Claim 6 (depends on 1) The apparatus of claim 1, wherein the absolute value computation module is further configured to compute an average absolute value based on the absolute values, wherein the final glucose reading is computed based on the average absolute value. ### Claim 7 (depends on 1) The apparatus of claim 1, further comprising error rectification module of the calibration logic to identify and rectify one or more errors associated with the computation of the absolute values. ### Claim 8 (depends on 1) The apparatus of claim 1, wherein the light source includes an emission control component in a top chamber or a bottom chamber of the apparatus to emit the light, and wherein the light sensor includes a reception control component in the top chamber or the bottom chamber of the apparatus to receive the light. ### Claim 9 A method comprising: receiving a body part including a finger, wherein the body part in the placement area causes interruptions in the running of a light; detecting initial readings corresponding to the interruptions, the initial readings including signals, wherein a signal is generated each time the light is interrupted while passing through the body part; calculating absolute values based on the initial readings; and computing a final glucose reading based on the absolute values. ### Claim 10 (depends on 9) The method of claim 9, further comprising emitting the light within a glucose monitoring device, wherein the light is received at a light sensor and runs in beams including an emitting beam and a receiving beam, wherein the final glucose reading is computed without having to pierce or pinch the body part. ### Claim 11 (depends on 9) The method of claim 9, further comprising: preparing the final glucose reading for presentation at a display screen; and displaying, via the display screen, the final glucose reading. ### Claim 12 (depends on 9) The method of claim 9, further comprising detecting the interruptions causing the signals, wherein the signals include analog signals. ### Claim 13 (depends on 12) The method of claim 12, further comprising converting the analog signals into digital signals, wherein the absolute values are computed based on the initial readings including the digital signals. ### Claim 14 (depends on 9) The method of claim 9, wherein the absolute value computation module is further configured to compute an average absolute value based on the absolute values, wherein the final glucose reading is computed based on the average absolute value. ### Claim 15 (depends on 9) The method of claim 9, further comprising identifying and rectifying one or more errors associated with the computation of the absolute values. ### Claim at position 16 16-21. (canceled) ### Claim 22 A machine-readable medium comprising a plurality of instructions, when executed on a computing device, causes the computing device to perform operations comprising: receiving a body part including a finger, wherein the body part in the placement area causes interruptions in the running of a light; detecting initial readings corresponding to the interruptions, the initial readings including signals, wherein a signal is generated each time the light is interrupted while passing through the body part; calculating absolute values based on the initial readings; and computing a final glucose reading based on the absolute values. ### Claim 23 (depends on 22) The machine-readable medium of claim 22, wherein the operations further comprise: emitting the light within a glucose monitoring device, wherein the light is received at a light sensor and runs in beams including an emitting beam and a receiving beam, wherein the final glucose reading is computed without having to pierce or pinch the body part; preparing the final glucose reading for presentation at a display screen; and displaying, via the display screen, the final glucose reading. ### Claim 24 (depends on 22) The machine-readable medium of claim 22, wherein the operations further comprise: detecting the interruptions causing the signals, wherein the signals include analog signals; and converting the analog signals into digital signals, wherein the absolute values are computed based on the initial readings including the digital signals. ### Claim 25 (depends on 22) The machine-readable medium of claim 22, wherein the absolute value computation module is further configured to compute an average absolute value based on the absolute values, wherein the final glucose reading is computed based on the average absolute value. ### Claim 26 (depends on 22) The machine-readable medium of claim 22, wherein the operations further comprise identifying and rectifying one or more errors associated with the computation of the absolute values.